Premium Reports
Contact KLAS
 Download Report    Zoom in charts



Related Series

 No Related Series

Related Segments

 End chart zoom
DrFirst DrFirst
* A page refresh may be necessary to see the updated image

First Look 2021

author - Aaron Gleave
Aaron Gleave
author - Joshua Jensen
Joshua Jensen
author - Spencer Larson
Spencer Larson
August 6, 2021 | Read Time: 1  minute

This report examines the experiences of early adopters of two DrFirst solutions: Medication Management Suite (MMS) and Backline. MMS combines the medication history of MedHx with the price transparency of myBenefitCheck and the automated prescription notifications of RxInform to help health systems improve medication reconciliation and adherence, thereby reducing the risk of readmissions and unnecessary costs. Backline is a comprehensive care collaboration and telehealth platform that aims to provide seamless, compliant, and secure communication (via messaging and telehealth) to internal and external clinical teams, patients, and caregivers. The first section of this report explores how MMS and Backline work together; the remainder of the report examines each solution separately.

Key Findings

  1. DrFirst: Company Profile at a Glance
  2. Medication Management Suite Customer Experience: An Initial Look
  3. Medication Management Suite: Adoption of Key Functionality
  4. Medication Management Suite: KLAS’ Points to Ponder
  5. Backline Customer Experience: An Initial Look
  6. Backline: Adoption of Key Functionality
  7. Backline: KLAS’ Points to Ponder
author - Madison Moniz
Madison Moniz
author - Joshua Jensen
Project Manager
Joshua Jensen
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments